Reviewed,
UniProtKB/Swiss-Prot Q2KL21 (EPOR_CANFA)
Last modified
June 16, 2009.
Version 24.
History...
Clusters with 100%,
90%,
50% identity |
Documents (1) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Erythropoietin receptor Short name=EPO-R | ||
| Gene names |
| ||
| Organism | Canis familiaris (Dog) | ||
| Taxonomic identifier | 9615 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Laurasiatheria › Carnivora › Caniformia › Canidae › Canis |
Protein attributes
| Sequence length | 508 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at transcript level. |
General annotation (Comments)
| Function | Receptor for erythropoietin. Mediates erythropoietin-induced erythroblast proliferation and differentiation. Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5 signaling cascade. In some cell types, can also activate STAT1 and STAT3. May also activate LYN tyrosine kinase By similarity. |
| Subunit structure | Forms homodimers on EPO stimulation. The tyrosine-phosphorylated form interacts with several SH2 domain-containing proteins including LYN, the adapter protein APS, PTPN6, PTPN11, JAK2, PI3 kinases, STAT5A/B, SOCS3 and CRKL. The N-terminal SH2 domain of PTPN6 binds Tyr-454 and inhibits signaling through dephosphorylation of JAK2. APS binding also inhibits the JAK-STAT signaling. Binding to PTPN11, preferentially through the N-terminal SH2 domain, promotes mitogenesis and phosphorylation of PTPN11. Binding of JAK2 (through its N-terminal) promotes cell-surface expression. Interaction with the ubiquitin ligase NOSIP mediates EPO-induced cell proliferation. Interacts with ATXN2L and INPP5D/SHIP1 By similarity. |
| Subcellular location | Membrane; Single-pass type I membrane protein By similarity. |
| Domain | The WSXWS motif appears to be necessary for proper protein folding and thereby efficient intracellular transport and cell-surface receptor binding. The box 1 motif is required for JAK interaction and/or activation. Contains 1 copy of a cytoplasmic motif that is referred to as the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is involved in modulation of cellular responses. The phosphorylated ITIM motif can bind the SH2 domain of several SH2-containing phosphatases. |
| Post-translational modification | On EPO stimulation, phosphorylated on C-terminal tyrosine residues by JAK2. The phosphotyrosine motifs are also recruitment sites for several SH2-containing proteins and adapter proteins which mediate cell proliferation. Phosphorylation on Tyr-454 is required for PTPN6 interaction, Tyr-426 for PTPN11. Tyr-426 is also required for SOCS3 binding, but Tyr-454/Tyr-456 motif is the preferred binding site By similarity. Ubiquitinated by NOSIP; appears to be either multi-monoubiquitinated or polyubiquitinated. Ubiquitination mediates proliferation and survival of EPO-dependent cells By similarity. |
| Sequence similarities | Belongs to the type I cytokine receptor family. Type 1 subfamily. Contains 1 fibronectin type-III domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Membrane |
| Domain | Signal Transmembrane |
| Molecular function | Receptor |
| PTM | Disulfide bond Glycoprotein Phosphoprotein Ubl conjugation |
| Gene Ontology (GO) | |
| Cellular component | integral to membrane Inferred from electronic annotation. Source: UniProtKB-KW |
| Molecular function | cytokine receptor activity Inferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 24 | 24 | Potential | ||||||||
| Chain | 25 – 508 | 484 | Erythropoietin receptor | PRO_0000231014 | |||||||
Regions | |||||||||||
| Topological domain | 25 – 250 | 226 | Extracellular Potential | ||||||||
| Transmembrane | 251 – 273 | 23 | Potential | ||||||||
| Topological domain | 274 – 508 | 235 | Cytoplasmic Potential | ||||||||
| Domain | 144 – 240 | 97 | Fibronectin type-III | ||||||||
| Region | 454 – 456 | 3 | Required for high-affinity SOCS3 binding | ||||||||
| Motif | 233 – 237 | 5 | WSXWS motif | ||||||||
| Motif | 282 – 290 | 9 | Box 1 motif | ||||||||
| Motif | 452 – 457 | 6 | ITIM motif | ||||||||
Sites | |||||||||||
| Site | 117 | 1 | Required for ligand binding By similarity | ||||||||
| Site | 368 | 1 | Interaction with APS and STAT5, and activation By similarity | ||||||||
| Site | 426 | 1 | Required for STAT5/PTPN11/SOCS3 binding By similarity | ||||||||
| Site | 454 | 1 | Interaction with PTPN6 By similarity | ||||||||
| Site | 456 | 1 | Required for STAT1/STAT3 activation | ||||||||
| Site | 485 | 1 | Required for CrkL binding By similarity | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 368 | 1 | Phosphotyrosine; by JAK2 By similarity | ||||||||
| Modified residue | 426 | 1 | Phosphotyrosine; by JAK2 By similarity | ||||||||
| Modified residue | 454 | 1 | Phosphotyrosine; by JAK2 By similarity | ||||||||
| Modified residue | 456 | 1 | Phosphotyrosine; by JAK2 By similarity | ||||||||
| Modified residue | 468 | 1 | Phosphotyrosine; by JAK2 By similarity | ||||||||
| Modified residue | 489 | 1 | Phosphotyrosine; by JAK2 By similarity | ||||||||
| Modified residue | 504 | 1 | Phosphotyrosine; by JAK2 By similarity | ||||||||
| Glycosylation | 76 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 184 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 52 ↔ 62 | By similarity | |||||||||
| Disulfide bond | 91 ↔ 107 | By similarity | |||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Transcriptional regulation of EPO-R during lung growth." Zhang Q., Moe O.W., Hsia C.C.W. Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
Cross-references
Sequence databases | |
|---|---|
| AY908987 mRNA. Translation: AAX89035.1. | |
| RefSeq | NP_001041576.1. |
| UniGene | Cfa.24663 |
3D structure databases | |
| SMR | Q2KL21. Positions 32-249. |
| ModBase | Search... |
Genome annotation databases | |
| Ensembl | ENSCAFG00000017411. Canis familiaris. [Contig view] |
| GeneID | 484943. |
| KEGG | cfa:484943. |
Phylogenomic databases | |
| HOVERGEN | Q2KL21. |
Family and domain databases | |
| InterPro | IPR015152. EpoR_lig-bind. IPR009167. Erythropoietin_rcpt. IPR008957. Fibronectin_typ-III-like_fold. IPR003961. FN_III. IPR003528. Long_hematopoietin_rcpt_CS. [Graphical view] |
| Gene3D | G3DSA:2.60.40.30. FN_III-like. 2 hits. |
| Pfam | PF09067. EpoR_lig-bind. 1 hit. PF00041. fn3. 1 hit. [Graphical view] |
| PIRSF | PIRSF001959. EPO_receptor. 1 hit. |
| SMART | SM00060. FN3. 1 hit. [Graphical view] |
| PROSITE | PS50853. FN3. 1 hit. PS01352. HEMATOPO_REC_L_F1. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Entry information
| Entry name | EPOR_CANFA | ||||||||
| Accession | Primary (citable) accession number: Q2KL21 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||

Clusters with


